Dhruv Bansal

Dhruv Bansal, MD, MBA

Began fellowship in 2019

Graduated in 2021


Initial post-graduate position:

Private Practice, St. Luke's Hospital, Kansas City, MO


2000-2006 MD, Smt. NHL Municipal Medical College, Ahmedabad, India
2016-2018 MBA, Washington University, St. Louis, MO
Post-graduate Training
2008-2011 Residency, Internal Medicine, University of New Mexico, Albuquerque, NM
2018-2019 Fellowship, Hematology & Oncology, Loma Linda University, Loma Linda, CA
2011-2014 Primary Care Physician, Hospitalist, Hospice Director, Pharmacy Director, St. Anthony Health Center, St. Louis, MO
2014-2018 Bone Marrow Transplant Hospitalist, Barnes Jewish-Hospital, St. Louis, MO
2016 Platinum Chapter Award, Society of Hospital Medicine
2017 Distinguished Faculty Award, Washington University School of Medicine


  • Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
    Bansal D, Reimers MA, Knoche EM, Pachynski RK
    Cancers (Basel) 2021 Jan 18;13(2)
  • Lenalidomide Results in a Durable Complete Remission in Acute Myeloid Leukemia Accompanied by Persistence of Somatic Mutations and a T-Cell Infiltrate in the Bone Marrow
    Bansal D, Vij K, Chang GS, Miller CA, DiPersio JF, Vij R, Heath SE, Westervelt P, Welch JS, Fehniger TA
    Haematologica 2018 Jun;103(6):e270-e273
  • Proteasome Inhibitor Associated Thrombotic Microangiopathy
    Yui JC, Van Keer J, Weiss BM, Waxman AJ, Palmer MB, D'Agati VD, Kastritis E, Dimopoulos MA, Vij R, Bansal D, Dingli D, Nasr SH, Leung N
    Am J Hematol 2016 Sep;91(9):E348-52

Book Chapters

  • Myelodysplastic Syndromes
    Bansal D, Bansal P
    Decision Support in Medicine: Hospital Medicine: 2nd edition. 2019 (
  • Chronic Myeloid Leukemia
    Bansal D, Bansal P
    Decision Support in Medicine: Hospital Medicine: 2nd edition. 2019 (